
Eagle Pharmaceuticals’ (EGRX) Line of Credit Reduced Amid Pending Restatement and Securities Fraud Class Action - Hagens Berman
SAN FRANCISCO, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) investors who suffered substantial losses to submit your losses now. Class Period: Aug. 8, 2023 – Nov. 28, 2023 Lead Plaintiff Deadline: Feb. 9, …